27 completed, 3 recruiting, 3 unknown, 2 terminated. 13 Not applicable, 11 Phase 1, 5 Phase 4, 4 Phase 3, 3 Phase 2.
Follow Syringes: new trials by email Literature Review of Syringes trials Research Report on Syringes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants Autoinjector, Vial and syringe - Healthy Adult Participants | Phase 1 | Recruiting | Astria Therapeutics, Inc. | 180 | 2026-04-21 | 2026-06-09 |
| Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule Pasireotide cartridge with reusable ServoPen, Pasireotide ampule with syringe - Pharmacokinetics, Safety | Phase 1 | Completed | RECORDATI GROUP | 40 | 2025-12-01 | 2026-02-04 |
| Comparing Effect of Opioid-sparing Versus Conventional Anesthesia on Quality of Recovery After Emergency Laparotomy : two syringes of lidocaine 10 mg/mL will be prepared. A 10-mL syringe (induction syringe) will be given during the induction of anesthesia and A 50 mL syringe (infusion syringe) will be used as conti, A 10-mL syringe of 10 mcg/mL fentanyl (induction syringe) and a 50-mL syringe of saline (infusion syringe) will be prepared as placebo. - Anesthesia Recovery Period | Not applicable | Not yet recruiting | Cairo University | 120 | 2025-04-20 | 2025-03-26 |
| EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders Hyaluronic acid, Syringes - Temporomandibular Joint Disorders, Arthrocentesis | Phase 1 / Phase 2 | Recruiting | Basel khaled mohamed | 30 | 2023-10-31 | 2024-11-19 |
| MALE HAIR LOSS - Treatment With Dutasteride Mesotherapy x Dutasteride MMP Technique (Injections With Tattoo Machine) MESOTHERAPY (INJECTIONS WITH SYRINGE AND NEEDLE), MMP (INJECTIONS WITH A TATTOO MACHINE) - Androgenic Alopecia | Phase 4 | Unknown | Clinica Dermatologica Arbache ltda | 60 | 2023-10-30 | 2023-11-01 |
| EpiFaith Resident Learning Curve Trial EpiFaith epidural syringe, Control (glass) syringe - Epidural Analgesia, Epidural Analgesia for Labour and Delivery | Not applicable | Recruiting | Brigham and Women's Hospital | 34 | 2023-09-01 | 2026-08-21 |
| Subcutaneous Abatacept in Renal Transplant Recipients Abatacept 125Mg/Ml Syringe - Kidney Transplant Recipient | Phase 1 | Completed | Idelberto Badell | 16 | 2023-08-02 | 2026-04-03 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations NR082 Injection, Injection needle - Leber Hereditary Optic Neuropathy (LHON) | Phase 1 / Phase 2 | Active not recruiting | Neurophth Therapeutics Inc | 12 | 2023-05-22 | 2024-09-04 |
| Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia Injection for SC administration (120mg/syringe), Tablet (50mg/tablet), oral - Dry Eye, Asthenopia | Completed | Nvision Laser Eye Centers | 103 | 2023-05-10 | 2024-06-03 | |
| Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe - Achondroplasia | Phase 1 | Terminated | BioMarin Pharmaceutical | 36 | 2023-03-15 | 2023-10-12 |
| A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema Icatibant - Hereditary Angioedema (HAE) | Completed | Takeda | 32 | 2022-08-24 | 2026-08-07 | |
| Superiority of Epidural Placement Technique Using EpiFaith Syringe Syringe - Anesthesia | Not applicable | Withdrawn | Harvard Medical School (HMS and HSDM) | 2022-05-15 | 2023-07-21 | |
| A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants Teduglutide, Syringe Injection, Pen injector - Healthy Volunteers | Phase 1 | Completed | Shire | 64 | 2021-01-13 | 2022-10-04 |
| Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Teduglutide, Standard Medical Therapy, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 10 | 2018-08-31 | 2021-05-11 |
| An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004 Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Takeda | 11 | 2018-07-09 | 2023-03-15 |
| Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Teduglutide, Syringe, Needle - Short Bowel Syndrome | Phase 3 | Completed | Shire | 7 | 2018-07-06 | 2020-08-04 |
| Comparison of Naloxone Pharmacokinetics Naloxone, Mucosal atomization device and syringe, Narcan - Opioid-use Disorder | Phase 1 | Completed | National Institute on Drug Abuse (NIDA) | 30 | 2018-01-03 | 2018-03-09 |
| Clinical Evaluation of Healthy Subjects Receiving Intradermal Saline Using the Microneedle Adapter (Model UAR-2S) Microneedle Adapter (Model UAR-2S), Hypodermic needle + syringe - Intradermal Injection | Not applicable | Completed | Microdermics Inc. | 20 | 2017-11-01 | 2018-01-30 |
| A Campaign-based ID fIPV Administration Trial ID adaptor, ID Jet Injector (Tropis, Pharmajet), Needle and syringe - Poliomyelitis | Not applicable | Completed | Medical Research Council Unit, The Gambia | 2721 | 2017-02-07 | 2019-01-03 |
| Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS) TED, SOC, Syringe - Short Bowel Syndrome | Phase 3 | Completed | Shire | 61 | 2017-01-09 | 2025-03-28 |
Showing 20 of 38. Sign in to see all of them.
Short Bowel Syndrome (4) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2) · Achondroplasia (1) · Alopecia (1) · Angioedemas, Hereditary (1) · Arthritis, Rheumatoid (1) · Asthenopia (1) · Constipation (1) · Drug Overdose (1) · Dry Eye Syndromes (1) · Hepatitis C, Chronic (1) · Hyperphagia (1) · Influenza, Human (1) · Kidney Failure, Chronic (1)
Shire (4) · Takeda (2) · AstraZeneca (1) · Astria Therapeutics, Inc. (1) · Augusta University (1) · Basel khaled mohamed (1) · BioMarin Pharmaceutical (1) · Brigham and Women's Hospital (1) · Cairo University (1) · Clinica Dermatologica Arbache ltda (1) · Harvard Medical School (HMS and HSDM) (1) · Hoffmann-La Roche (1) · Hospices Civils de Lyon (1) · Hospital de Clinicas de Porto Alegre (1) · Idelberto Badell (1)
United States (17) · Canada (3) · France (3) · Japan (3) · Brazil (2) · Finland (2) · Italy (2) · United Kingdom (2) · Belgium (1) · Egypt (1) · Germany (1) · India (1) · South Africa (1) · Taiwan (1) · Thailand (1)
Adedapo O Bashorun, MBBS (1) · Araya Satdhabudha, MD (1) · Basel K Mohamed (1) · Chen-Hua Liu, M.D. (1) · Daniel Perlman, MD, MBA (1) · Danielle Armas, MD (1) · Daryl C Osbahr, MD (1) · Debra Kelsh, MD (1) · Ed Clarke, MRCPCH MSc PhD (1) · Elise Hardy, MD (1) · Eric Ahn (1) · Hennie Geldenhuys (1)
PMID 16339287, PMID 16511940, PMID 17143968, PMID 17278943, PMID 17885154, PMID 18281176, PMID 19037606, PMID 19265345, PMID 19648304, PMID 21057794, PMID 21078710, PMID 21127362, PMID 21447197, PMID 21469942, PMID 21617556, PMID 22452536, PMID 23883424, PMID 24925504, PMID 30899835, PMID 34118981, PMID 34951974, PMID 37096802, PMID 37364133, PMID 38873891, PMID 41858082
2016 (1), 2017 (1), U01AI138909 (1)